nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—CA9—Hydrochlorothiazide—nephrolithiasis	0.199	0.267	CbGbCtD
Imatinib—CA12—Hydrochlorothiazide—nephrolithiasis	0.199	0.267	CbGbCtD
Imatinib—CA1—Hydrochlorothiazide—nephrolithiasis	0.186	0.25	CbGbCtD
Imatinib—CA2—Hydrochlorothiazide—nephrolithiasis	0.161	0.216	CbGbCtD
Imatinib—CA2—collecting duct of renal tubule—nephrolithiasis	0.00602	0.0839	CbGeAlD
Imatinib—SLC22A2—nephron—nephrolithiasis	0.00537	0.0748	CbGeAlD
Imatinib—DDR1—nephron tubule—nephrolithiasis	0.0027	0.0376	CbGeAlD
Imatinib—Joint swelling—Hydrochlorothiazide—nephrolithiasis	0.00265	0.025	CcSEcCtD
Imatinib—ABCA3—cortex of kidney—nephrolithiasis	0.0025	0.0349	CbGeAlD
Imatinib—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00247	0.0234	CcSEcCtD
Imatinib—CYP2C19—urine—nephrolithiasis	0.00234	0.0327	CbGeAlD
Imatinib—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00232	0.0219	CcSEcCtD
Imatinib—DDR1—cortex of kidney—nephrolithiasis	0.00231	0.0322	CbGeAlD
Imatinib—CYP1A2—urine—nephrolithiasis	0.00191	0.0267	CbGeAlD
Imatinib—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00189	0.0178	CcSEcCtD
Imatinib—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.00189	0.0178	CcSEcCtD
Imatinib—CYP2C9—urine—nephrolithiasis	0.00182	0.0253	CbGeAlD
Imatinib—PIP4K2C—nephron tubule—nephrolithiasis	0.00167	0.0232	CbGeAlD
Imatinib—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.00165	0.0157	CcSEcCtD
Imatinib—CA7—renal system—nephrolithiasis	0.00158	0.022	CbGeAlD
Imatinib—CA7—kidney—nephrolithiasis	0.00152	0.0212	CbGeAlD
Imatinib—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00147	0.0139	CcSEcCtD
Imatinib—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00145	0.0137	CcSEcCtD
Imatinib—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00144	0.0136	CcSEcCtD
Imatinib—PIP4K2C—cortex of kidney—nephrolithiasis	0.00143	0.0199	CbGeAlD
Imatinib—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.0014	0.0132	CcSEcCtD
Imatinib—Gout—Hydrochlorothiazide—nephrolithiasis	0.00139	0.0132	CcSEcCtD
Imatinib—CYP3A4—urine—nephrolithiasis	0.00139	0.0193	CbGeAlD
Imatinib—CYP2D6—urine—nephrolithiasis	0.00136	0.019	CbGeAlD
Imatinib—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00135	0.0128	CcSEcCtD
Imatinib—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00133	0.0126	CcSEcCtD
Imatinib—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00132	0.0125	CcSEcCtD
Imatinib—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.00131	0.0124	CcSEcCtD
Imatinib—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00128	0.0121	CcSEcCtD
Imatinib—NQO2—nephron tubule—nephrolithiasis	0.00122	0.017	CbGeAlD
Imatinib—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00122	0.0115	CcSEcCtD
Imatinib—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.0012	0.0167	CbGeAlD
Imatinib—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00119	0.0112	CcSEcCtD
Imatinib—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00117	0.0111	CcSEcCtD
Imatinib—SLC22A2—nephron tubule—nephrolithiasis	0.00116	0.0162	CbGeAlD
Imatinib—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00116	0.0109	CcSEcCtD
Imatinib—NQO2—renal system—nephrolithiasis	0.00111	0.0155	CbGeAlD
Imatinib—PDGFRA—renal system—nephrolithiasis	0.00111	0.0155	CbGeAlD
Imatinib—NQO2—kidney—nephrolithiasis	0.00108	0.015	CbGeAlD
Imatinib—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00106	0.0101	CcSEcCtD
Imatinib—SLC22A2—renal system—nephrolithiasis	0.00105	0.0147	CbGeAlD
Imatinib—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00105	0.00997	CcSEcCtD
Imatinib—NQO2—cortex of kidney—nephrolithiasis	0.00105	0.0146	CbGeAlD
Imatinib—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00104	0.00988	CcSEcCtD
Imatinib—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.00103	0.0143	CbGeAlD
Imatinib—CA12—renal system—nephrolithiasis	0.00102	0.0143	CbGeAlD
Imatinib—SLC22A2—kidney—nephrolithiasis	0.00102	0.0142	CbGeAlD
Imatinib—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00102	0.00962	CcSEcCtD
Imatinib—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.001	0.00949	CcSEcCtD
Imatinib—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.000998	0.00945	CcSEcCtD
Imatinib—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.000994	0.00941	CcSEcCtD
Imatinib—SLC22A2—cortex of kidney—nephrolithiasis	0.000992	0.0138	CbGeAlD
Imatinib—CA12—kidney—nephrolithiasis	0.00099	0.0138	CbGeAlD
Imatinib—SLC47A1—nephron tubule—nephrolithiasis	0.000981	0.0137	CbGeAlD
Imatinib—Purpura—Hydrochlorothiazide—nephrolithiasis	0.000978	0.00925	CcSEcCtD
Imatinib—KIT—nephron tubule—nephrolithiasis	0.000975	0.0136	CbGeAlD
Imatinib—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.000969	0.00917	CcSEcCtD
Imatinib—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.000946	0.00895	CcSEcCtD
Imatinib—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.000942	0.00892	CcSEcCtD
Imatinib—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.000942	0.00892	CcSEcCtD
Imatinib—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.000935	0.00885	CcSEcCtD
Imatinib—Migraine—Hydrochlorothiazide—nephrolithiasis	0.000927	0.00878	CcSEcCtD
Imatinib—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00091	0.00861	CcSEcCtD
Imatinib—SLC47A1—renal system—nephrolithiasis	0.000892	0.0124	CbGeAlD
Imatinib—KIT—renal system—nephrolithiasis	0.000887	0.0124	CbGeAlD
Imatinib—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.000883	0.00835	CcSEcCtD
Imatinib—PDGFRB—renal system—nephrolithiasis	0.000866	0.0121	CbGeAlD
Imatinib—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.000864	0.00817	CcSEcCtD
Imatinib—SLC47A1—kidney—nephrolithiasis	0.000862	0.012	CbGeAlD
Imatinib—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.000861	0.00814	CcSEcCtD
Imatinib—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.000857	0.00812	CcSEcCtD
Imatinib—KIT—kidney—nephrolithiasis	0.000857	0.0119	CbGeAlD
Imatinib—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.000851	0.00806	CcSEcCtD
Imatinib—ABL1—nephron tubule—nephrolithiasis	0.000849	0.0118	CbGeAlD
Imatinib—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.000848	0.00803	CcSEcCtD
Imatinib—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.000848	0.00803	CcSEcCtD
Imatinib—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.000848	0.00803	CcSEcCtD
Imatinib—SLC47A1—cortex of kidney—nephrolithiasis	0.00084	0.0117	CbGeAlD
Imatinib—PDGFRB—kidney—nephrolithiasis	0.000837	0.0117	CbGeAlD
Imatinib—KIT—cortex of kidney—nephrolithiasis	0.000835	0.0116	CbGeAlD
Imatinib—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.000834	0.00789	CcSEcCtD
Imatinib—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.000831	0.00786	CcSEcCtD
Imatinib—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.000831	0.00786	CcSEcCtD
Imatinib—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00082	0.00776	CcSEcCtD
Imatinib—PDGFRB—cortex of kidney—nephrolithiasis	0.000815	0.0114	CbGeAlD
Imatinib—Influenza—Hydrochlorothiazide—nephrolithiasis	0.000814	0.00771	CcSEcCtD
Imatinib—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.000814	0.00771	CcSEcCtD
Imatinib—CA1—renal system—nephrolithiasis	0.000811	0.0113	CbGeAlD
Imatinib—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.000798	0.00756	CcSEcCtD
Imatinib—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.000793	0.00751	CcSEcCtD
Imatinib—CA1—kidney—nephrolithiasis	0.000784	0.0109	CbGeAlD
Imatinib—ABL1—renal system—nephrolithiasis	0.000772	0.0108	CbGeAlD
Imatinib—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.000761	0.00721	CcSEcCtD
Imatinib—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.000757	0.00716	CcSEcCtD
Imatinib—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.000752	0.00712	CcSEcCtD
Imatinib—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00075	0.0071	CcSEcCtD
Imatinib—ABL1—kidney—nephrolithiasis	0.000746	0.0104	CbGeAlD
Imatinib—SLC22A1—renal system—nephrolithiasis	0.000744	0.0104	CbGeAlD
Imatinib—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.000743	0.00703	CcSEcCtD
Imatinib—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.000741	0.00701	CcSEcCtD
Imatinib—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.000735	0.00695	CcSEcCtD
Imatinib—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00073	0.00691	CcSEcCtD
Imatinib—ABL1—cortex of kidney—nephrolithiasis	0.000727	0.0101	CbGeAlD
Imatinib—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00072	0.00681	CcSEcCtD
Imatinib—SLC22A1—kidney—nephrolithiasis	0.000719	0.01	CbGeAlD
Imatinib—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.000716	0.00677	CcSEcCtD
Imatinib—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.000714	0.00675	CcSEcCtD
Imatinib—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.000712	0.00674	CcSEcCtD
Imatinib—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.000712	0.00674	CcSEcCtD
Imatinib—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.000708	0.0067	CcSEcCtD
Imatinib—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.000706	0.00668	CcSEcCtD
Imatinib—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.000706	0.00668	CcSEcCtD
Imatinib—Sweating—Hydrochlorothiazide—nephrolithiasis	0.000696	0.00659	CcSEcCtD
Imatinib—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.000692	0.00655	CcSEcCtD
Imatinib—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.000685	0.00648	CcSEcCtD
Imatinib—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.000681	0.00645	CcSEcCtD
Imatinib—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.000678	0.00641	CcSEcCtD
Imatinib—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.000653	0.00618	CcSEcCtD
Imatinib—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.000652	0.00617	CcSEcCtD
Imatinib—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.000649	0.00614	CcSEcCtD
Imatinib—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.000647	0.00612	CcSEcCtD
Imatinib—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.000642	0.00608	CcSEcCtD
Imatinib—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.000616	0.00583	CcSEcCtD
Imatinib—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000608	0.00575	CcSEcCtD
Imatinib—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000605	0.00572	CcSEcCtD
Imatinib—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000582	0.00551	CcSEcCtD
Imatinib—CA2—nephron tubule—nephrolithiasis	0.000578	0.00806	CbGeAlD
Imatinib—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.000576	0.00545	CcSEcCtD
Imatinib—Erythema—Hydrochlorothiazide—nephrolithiasis	0.000567	0.00537	CcSEcCtD
Imatinib—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.000559	0.00529	CcSEcCtD
Imatinib—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000556	0.00526	CcSEcCtD
Imatinib—Back pain—Hydrochlorothiazide—nephrolithiasis	0.000549	0.00519	CcSEcCtD
Imatinib—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.000546	0.00516	CcSEcCtD
Imatinib—ABCG2—nephron tubule—nephrolithiasis	0.000535	0.00746	CbGeAlD
Imatinib—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.000535	0.00506	CcSEcCtD
Imatinib—Tremor—Hydrochlorothiazide—nephrolithiasis	0.000532	0.00503	CcSEcCtD
Imatinib—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.000526	0.00498	CcSEcCtD
Imatinib—CA2—renal system—nephrolithiasis	0.000526	0.00733	CbGeAlD
Imatinib—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.000524	0.00496	CcSEcCtD
Imatinib—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.000518	0.00491	CcSEcCtD
Imatinib—Malaise—Hydrochlorothiazide—nephrolithiasis	0.000512	0.00484	CcSEcCtD
Imatinib—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00051	0.00482	CcSEcCtD
Imatinib—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000509	0.00482	CcSEcCtD
Imatinib—CA2—kidney—nephrolithiasis	0.000508	0.00708	CbGeAlD
Imatinib—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000508	0.00481	CcSEcCtD
Imatinib—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000501	0.00475	CcSEcCtD
Imatinib—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000499	0.00472	CcSEcCtD
Imatinib—CYP3A5—nephron tubule—nephrolithiasis	0.000497	0.00693	CbGeAlD
Imatinib—Cough—Hydrochlorothiazide—nephrolithiasis	0.000495	0.00469	CcSEcCtD
Imatinib—CA2—cortex of kidney—nephrolithiasis	0.000495	0.0069	CbGeAlD
Imatinib—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000483	0.00457	CcSEcCtD
Imatinib—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.000483	0.00457	CcSEcCtD
Imatinib—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.000483	0.00457	CcSEcCtD
Imatinib—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000481	0.00456	CcSEcCtD
Imatinib—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.000477	0.00452	CcSEcCtD
Imatinib—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000472	0.00447	CcSEcCtD
Imatinib—CYP1A2—renal system—nephrolithiasis	0.000468	0.00653	CbGeAlD
Imatinib—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000467	0.00442	CcSEcCtD
Imatinib—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000463	0.00438	CcSEcCtD
Imatinib—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000463	0.00438	CcSEcCtD
Imatinib—Shock—Hydrochlorothiazide—nephrolithiasis	0.000456	0.00431	CcSEcCtD
Imatinib—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000453	0.00429	CcSEcCtD
Imatinib—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000452	0.00428	CcSEcCtD
Imatinib—CYP3A5—renal system—nephrolithiasis	0.000452	0.0063	CbGeAlD
Imatinib—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000448	0.00424	CcSEcCtD
Imatinib—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000441	0.00418	CcSEcCtD
Imatinib—CYP3A5—kidney—nephrolithiasis	0.000437	0.00609	CbGeAlD
Imatinib—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000433	0.0041	CcSEcCtD
Imatinib—CYP3A5—cortex of kidney—nephrolithiasis	0.000425	0.00593	CbGeAlD
Imatinib—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000422	0.00399	CcSEcCtD
Imatinib—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000419	0.00396	CcSEcCtD
Imatinib—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000416	0.00394	CcSEcCtD
Imatinib—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000413	0.00391	CcSEcCtD
Imatinib—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000412	0.0039	CcSEcCtD
Imatinib—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000408	0.00386	CcSEcCtD
Imatinib—PTGS1—renal system—nephrolithiasis	0.000406	0.00566	CbGeAlD
Imatinib—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000403	0.00381	CcSEcCtD
Imatinib—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000399	0.00378	CcSEcCtD
Imatinib—Pain—Hydrochlorothiazide—nephrolithiasis	0.000396	0.00375	CcSEcCtD
Imatinib—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000396	0.00375	CcSEcCtD
Imatinib—PTGS1—kidney—nephrolithiasis	0.000392	0.00547	CbGeAlD
Imatinib—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000382	0.00361	CcSEcCtD
Imatinib—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000379	0.00358	CcSEcCtD
Imatinib—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000368	0.00348	CcSEcCtD
Imatinib—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000366	0.00346	CcSEcCtD
Imatinib—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000366	0.00346	CcSEcCtD
Imatinib—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000341	0.00323	CcSEcCtD
Imatinib—CYP3A4—renal system—nephrolithiasis	0.000339	0.00473	CbGeAlD
Imatinib—CYP2D6—renal system—nephrolithiasis	0.000334	0.00465	CbGeAlD
Imatinib—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000332	0.00314	CcSEcCtD
Imatinib—CYP3A4—kidney—nephrolithiasis	0.000328	0.00457	CbGeAlD
Imatinib—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000328	0.0031	CcSEcCtD
Imatinib—CYP2D6—kidney—nephrolithiasis	0.000323	0.0045	CbGeAlD
Imatinib—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000317	0.003	CcSEcCtD
Imatinib—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000306	0.0029	CcSEcCtD
Imatinib—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000294	0.00279	CcSEcCtD
Imatinib—Rash—Hydrochlorothiazide—nephrolithiasis	0.000292	0.00276	CcSEcCtD
Imatinib—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000292	0.00276	CcSEcCtD
Imatinib—Headache—Hydrochlorothiazide—nephrolithiasis	0.00029	0.00275	CcSEcCtD
Imatinib—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000275	0.0026	CcSEcCtD
Imatinib—ABCB1—nephron tubule—nephrolithiasis	0.000264	0.00368	CbGeAlD
Imatinib—ABCB1—renal system—nephrolithiasis	0.00024	0.00335	CbGeAlD
Imatinib—ABCB1—kidney—nephrolithiasis	0.000232	0.00323	CbGeAlD
Imatinib—ABCB1—cortex of kidney—nephrolithiasis	0.000226	0.00315	CbGeAlD
Imatinib—CA12—Metabolism—GRHPR—nephrolithiasis	0.000193	0.00243	CbGpPWpGaD
Imatinib—CA3—Metabolism—AQP1—nephrolithiasis	0.000192	0.00242	CbGpPWpGaD
Imatinib—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000191	0.00241	CbGpPWpGaD
Imatinib—CA7—Metabolism—AGXT—nephrolithiasis	0.000185	0.00234	CbGpPWpGaD
Imatinib—SLC22A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000184	0.00233	CbGpPWpGaD
Imatinib—SLC22A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000184	0.00233	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000177	0.00223	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000177	0.00223	CbGpPWpGaD
Imatinib—SLC22A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000176	0.00222	CbGpPWpGaD
Imatinib—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000175	0.00221	CbGpPWpGaD
Imatinib—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000175	0.00221	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000175	0.00221	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000175	0.00221	CbGpPWpGaD
Imatinib—CA14—Metabolism—SLC26A1—nephrolithiasis	0.000173	0.00219	CbGpPWpGaD
Imatinib—CA14—Metabolism—APRT—nephrolithiasis	0.000173	0.00219	CbGpPWpGaD
Imatinib—CA3—Metabolism—CHRM3—nephrolithiasis	0.000173	0.00219	CbGpPWpGaD
Imatinib—CA12—Metabolism—AGXT—nephrolithiasis	0.000172	0.00217	CbGpPWpGaD
Imatinib—CA6—Metabolism—SLC26A1—nephrolithiasis	0.000169	0.00213	CbGpPWpGaD
Imatinib—CA6—Metabolism—APRT—nephrolithiasis	0.000169	0.00213	CbGpPWpGaD
Imatinib—SLC22A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000164	0.00207	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000163	0.00206	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000163	0.00206	CbGpPWpGaD
Imatinib—CA7—Metabolism—SLC26A1—nephrolithiasis	0.000158	0.00199	CbGpPWpGaD
Imatinib—CA7—Metabolism—APRT—nephrolithiasis	0.000158	0.00199	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000158	0.00199	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000156	0.00197	CbGpPWpGaD
Imatinib—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.000154	0.00194	CbGpPWpGaD
Imatinib—CA2—Metabolism—GRHPR—nephrolithiasis	0.000147	0.00186	CbGpPWpGaD
Imatinib—CA12—Metabolism—SLC26A1—nephrolithiasis	0.000146	0.00184	CbGpPWpGaD
Imatinib—CA12—Metabolism—APRT—nephrolithiasis	0.000146	0.00184	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000145	0.00183	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000144	0.00182	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000144	0.00182	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000143	0.0018	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000143	0.0018	CbGpPWpGaD
Imatinib—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000142	0.00179	CbGpPWpGaD
Imatinib—CA1—Metabolism—GRHPR—nephrolithiasis	0.000141	0.00178	CbGpPWpGaD
Imatinib—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.00014	0.00177	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000133	0.00168	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000133	0.00168	CbGpPWpGaD
Imatinib—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000133	0.00167	CbGpPWpGaD
Imatinib—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000133	0.00167	CbGpPWpGaD
Imatinib—CA2—Metabolism—AGXT—nephrolithiasis	0.000131	0.00166	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—SLC7A9—nephrolithiasis	0.000131	0.00165	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—DGKH—nephrolithiasis	0.000131	0.00165	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—ADCY10—nephrolithiasis	0.000127	0.0016	CbGpPWpGaD
Imatinib—CA1—Metabolism—AGXT—nephrolithiasis	0.000126	0.00159	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000125	0.00158	CbGpPWpGaD
Imatinib—CA9—Metabolism—GRHPR—nephrolithiasis	0.000124	0.00157	CbGpPWpGaD
Imatinib—CA14—Metabolism—AQP1—nephrolithiasis	0.000123	0.00156	CbGpPWpGaD
Imatinib—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000123	0.00156	CbGpPWpGaD
Imatinib—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000123	0.00156	CbGpPWpGaD
Imatinib—CA6—Metabolism—AQP1—nephrolithiasis	0.00012	0.00152	CbGpPWpGaD
Imatinib—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.00012	0.00151	CbGpPWpGaD
Imatinib—KIT—Signaling by PDGF—SPP1—nephrolithiasis	0.000119	0.0015	CbGpPWpGaD
Imatinib—CA7—Metabolism—AQP1—nephrolithiasis	0.000112	0.00142	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by PDGF—SPP1—nephrolithiasis	0.000112	0.00142	CbGpPWpGaD
Imatinib—CA14—Metabolism—CHRM3—nephrolithiasis	0.000112	0.00141	CbGpPWpGaD
Imatinib—CA2—Metabolism—SLC26A1—nephrolithiasis	0.000112	0.00141	CbGpPWpGaD
Imatinib—CA2—Metabolism—APRT—nephrolithiasis	0.000112	0.00141	CbGpPWpGaD
Imatinib—CA9—Metabolism—AGXT—nephrolithiasis	0.000111	0.0014	CbGpPWpGaD
Imatinib—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00011	0.00139	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000109	0.00138	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000109	0.00138	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000109	0.00138	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000109	0.00138	CbGpPWpGaD
Imatinib—CA6—Metabolism—CHRM3—nephrolithiasis	0.000109	0.00137	CbGpPWpGaD
Imatinib—PDGFRA—Focal Adhesion—SPP1—nephrolithiasis	0.000108	0.00137	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000108	0.00136	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000108	0.00136	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—RGS14—nephrolithiasis	0.000108	0.00136	CbGpPWpGaD
Imatinib—LCK—Hemostasis—SLC7A9—nephrolithiasis	0.000108	0.00136	CbGpPWpGaD
Imatinib—LCK—Hemostasis—DGKH—nephrolithiasis	0.000108	0.00136	CbGpPWpGaD
Imatinib—CA1—Metabolism—APRT—nephrolithiasis	0.000107	0.00135	CbGpPWpGaD
Imatinib—CA1—Metabolism—SLC26A1—nephrolithiasis	0.000107	0.00135	CbGpPWpGaD
Imatinib—CA12—Metabolism—AQP1—nephrolithiasis	0.000104	0.00131	CbGpPWpGaD
Imatinib—CA7—Metabolism—CHRM3—nephrolithiasis	0.000102	0.00128	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000101	0.00128	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000101	0.00128	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by PDGF—SPP1—nephrolithiasis	0.000101	0.00128	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000101	0.00127	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000101	0.00127	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0001	0.00127	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0001	0.00127	CbGpPWpGaD
Imatinib—PDGFRB—Focal Adhesion—SPP1—nephrolithiasis	9.77e-05	0.00123	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	9.72e-05	0.00123	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	9.55e-05	0.00121	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	9.55e-05	0.00121	CbGpPWpGaD
Imatinib—CA9—Metabolism—SLC26A1—nephrolithiasis	9.41e-05	0.00119	CbGpPWpGaD
Imatinib—CA9—Metabolism—APRT—nephrolithiasis	9.41e-05	0.00119	CbGpPWpGaD
Imatinib—CA12—Metabolism—CHRM3—nephrolithiasis	9.41e-05	0.00119	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	9.36e-05	0.00118	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	9.36e-05	0.00118	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—ADCY10—nephrolithiasis	9.3e-05	0.00117	CbGpPWpGaD
Imatinib—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	9.26e-05	0.00117	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	9.05e-05	0.00114	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	9.05e-05	0.00114	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	8.95e-05	0.00113	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	8.95e-05	0.00113	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	8.89e-05	0.00112	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	8.89e-05	0.00112	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—ADCY10—nephrolithiasis	8.81e-05	0.00111	CbGpPWpGaD
Imatinib—KIT—Disease—SLC26A1—nephrolithiasis	8.56e-05	0.00108	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	8.52e-05	0.00107	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	8.34e-05	0.00105	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	8.34e-05	0.00105	CbGpPWpGaD
Imatinib—LCK—Signaling by PDGF—SPP1—nephrolithiasis	8.11e-05	0.00102	CbGpPWpGaD
Imatinib—PDGFRA—Disease—SLC26A1—nephrolithiasis	8.1e-05	0.00102	CbGpPWpGaD
Imatinib—CA2—Metabolism—AQP1—nephrolithiasis	7.95e-05	0.001	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—ADCY10—nephrolithiasis	7.93e-05	0.001	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—RGS14—nephrolithiasis	7.91e-05	0.000999	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	7.79e-05	0.000983	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	7.79e-05	0.000983	CbGpPWpGaD
Imatinib—KIT—Disease—ATP6V0A4—nephrolithiasis	7.63e-05	0.000963	CbGpPWpGaD
Imatinib—CA1—Metabolism—AQP1—nephrolithiasis	7.62e-05	0.000962	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—RGS14—nephrolithiasis	7.49e-05	0.000945	CbGpPWpGaD
Imatinib—PDGFRB—Disease—SLC26A1—nephrolithiasis	7.3e-05	0.000922	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—DGKH—nephrolithiasis	7.29e-05	0.000921	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.29e-05	0.000921	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	7.23e-05	0.000913	CbGpPWpGaD
Imatinib—PDGFRA—Disease—ATP6V0A4—nephrolithiasis	7.22e-05	0.000912	CbGpPWpGaD
Imatinib—CA2—Metabolism—CHRM3—nephrolithiasis	7.19e-05	0.000908	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	7.16e-05	0.000903	CbGpPWpGaD
Imatinib—CA1—Metabolism—CHRM3—nephrolithiasis	6.89e-05	0.00087	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—RGS14—nephrolithiasis	6.75e-05	0.000852	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	6.74e-05	0.00085	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	6.74e-05	0.00085	CbGpPWpGaD
Imatinib—CA9—Metabolism—AQP1—nephrolithiasis	6.7e-05	0.000846	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	6.67e-05	0.000842	CbGpPWpGaD
Imatinib—PDGFRB—Disease—ATP6V0A4—nephrolithiasis	6.51e-05	0.000821	CbGpPWpGaD
Imatinib—ALB—Hemostasis—DGKH—nephrolithiasis	6.45e-05	0.000814	CbGpPWpGaD
Imatinib—ALB—Hemostasis—SLC7A9—nephrolithiasis	6.45e-05	0.000814	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ADCY10—nephrolithiasis	6.37e-05	0.000804	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GRHPR—nephrolithiasis	6.27e-05	0.000792	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	6.26e-05	0.000791	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	6.26e-05	0.000791	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GRHPR—nephrolithiasis	6.22e-05	0.000785	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GRHPR—nephrolithiasis	6.21e-05	0.000784	CbGpPWpGaD
Imatinib—CA9—Metabolism—CHRM3—nephrolithiasis	6.06e-05	0.000765	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GRHPR—nephrolithiasis	6.03e-05	0.000761	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	5.9e-05	0.000745	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	5.9e-05	0.000745	CbGpPWpGaD
Imatinib—LCK—Disease—SLC26A1—nephrolithiasis	5.86e-05	0.00074	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GRHPR—nephrolithiasis	5.79e-05	0.00073	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—AGXT—nephrolithiasis	5.59e-05	0.000706	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	5.58e-05	0.000705	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	5.58e-05	0.000705	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—AGXT—nephrolithiasis	5.54e-05	0.0007	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—AGXT—nephrolithiasis	5.53e-05	0.000698	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	5.49e-05	0.000693	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	5.49e-05	0.000693	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—RGS14—nephrolithiasis	5.41e-05	0.000683	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—AGXT—nephrolithiasis	5.37e-05	0.000678	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.34e-05	0.000675	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—DGKH—nephrolithiasis	5.34e-05	0.000675	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CHRM3—nephrolithiasis	5.27e-05	0.000666	CbGpPWpGaD
Imatinib—LCK—Disease—ATP6V0A4—nephrolithiasis	5.22e-05	0.000659	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—AGXT—nephrolithiasis	5.16e-05	0.000651	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.06e-05	0.000639	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—DGKH—nephrolithiasis	5.06e-05	0.000639	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	4.89e-05	0.000617	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	4.89e-05	0.000617	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—PTH—nephrolithiasis	4.82e-05	0.000609	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—SLC26A1—nephrolithiasis	4.75e-05	0.0006	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—APRT—nephrolithiasis	4.75e-05	0.0006	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—APRT—nephrolithiasis	4.71e-05	0.000595	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—SLC26A1—nephrolithiasis	4.71e-05	0.000595	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—SLC26A1—nephrolithiasis	4.7e-05	0.000594	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—APRT—nephrolithiasis	4.7e-05	0.000594	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—APRT—nephrolithiasis	4.57e-05	0.000577	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—SLC26A1—nephrolithiasis	4.57e-05	0.000577	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.56e-05	0.000575	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—DGKH—nephrolithiasis	4.56e-05	0.000575	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GRHPR—nephrolithiasis	4.49e-05	0.000567	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	4.46e-05	0.000563	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—SLC26A1—nephrolithiasis	4.39e-05	0.000554	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—APRT—nephrolithiasis	4.39e-05	0.000554	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—AGXT—nephrolithiasis	4.01e-05	0.000506	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	3.91e-05	0.000494	CbGpPWpGaD
Imatinib—ALB—Metabolism—GRHPR—nephrolithiasis	3.87e-05	0.000489	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CHRM3—nephrolithiasis	3.86e-05	0.000488	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—DGKH—nephrolithiasis	3.66e-05	0.000462	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CHRM3—nephrolithiasis	3.66e-05	0.000462	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.66e-05	0.000462	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—PTH—nephrolithiasis	3.53e-05	0.000446	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GRHPR—nephrolithiasis	3.47e-05	0.000439	CbGpPWpGaD
Imatinib—ALB—Metabolism—AGXT—nephrolithiasis	3.45e-05	0.000435	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—APRT—nephrolithiasis	3.41e-05	0.00043	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	3.41e-05	0.00043	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GRHPR—nephrolithiasis	3.39e-05	0.000428	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—AQP1—nephrolithiasis	3.39e-05	0.000428	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—AQP1—nephrolithiasis	3.36e-05	0.000424	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—AQP1—nephrolithiasis	3.35e-05	0.000423	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—PTH—nephrolithiasis	3.34e-05	0.000422	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CHRM3—nephrolithiasis	3.29e-05	0.000416	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—AQP1—nephrolithiasis	3.25e-05	0.000411	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GRHPR—nephrolithiasis	3.2e-05	0.000403	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GRHPR—nephrolithiasis	3.17e-05	0.0004	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—AQP1—nephrolithiasis	3.12e-05	0.000394	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—AGXT—nephrolithiasis	3.1e-05	0.000391	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CHRM3—nephrolithiasis	3.06e-05	0.000387	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CHRM3—nephrolithiasis	3.04e-05	0.000383	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CHRM3—nephrolithiasis	3.03e-05	0.000383	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—AGXT—nephrolithiasis	3.02e-05	0.000382	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—PTH—nephrolithiasis	3.01e-05	0.00038	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CHRM3—nephrolithiasis	2.94e-05	0.000372	CbGpPWpGaD
Imatinib—ALB—Metabolism—SLC26A1—nephrolithiasis	2.93e-05	0.00037	CbGpPWpGaD
Imatinib—ALB—Metabolism—APRT—nephrolithiasis	2.93e-05	0.00037	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—AGXT—nephrolithiasis	2.85e-05	0.00036	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CHRM3—nephrolithiasis	2.83e-05	0.000357	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—AGXT—nephrolithiasis	2.82e-05	0.000356	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GRHPR—nephrolithiasis	2.71e-05	0.000342	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CHRM3—nephrolithiasis	2.64e-05	0.000334	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	2.63e-05	0.000332	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—APRT—nephrolithiasis	2.63e-05	0.000332	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—SLC26A1—nephrolithiasis	2.57e-05	0.000324	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—APRT—nephrolithiasis	2.57e-05	0.000324	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—AQP1—nephrolithiasis	2.43e-05	0.000306	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	2.42e-05	0.000306	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—APRT—nephrolithiasis	2.42e-05	0.000306	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—SPP1—nephrolithiasis	2.42e-05	0.000306	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PTH—nephrolithiasis	2.42e-05	0.000305	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—AGXT—nephrolithiasis	2.41e-05	0.000305	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—APRT—nephrolithiasis	2.4e-05	0.000303	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	2.4e-05	0.000303	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CHRM3—nephrolithiasis	2.19e-05	0.000277	CbGpPWpGaD
Imatinib—ALB—Metabolism—AQP1—nephrolithiasis	2.09e-05	0.000264	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GRHPR—nephrolithiasis	2.09e-05	0.000264	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APRT—nephrolithiasis	2.05e-05	0.000259	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	2.05e-05	0.000259	CbGpPWpGaD
Imatinib—ALB—Metabolism—CHRM3—nephrolithiasis	1.89e-05	0.000239	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—AQP1—nephrolithiasis	1.88e-05	0.000237	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—AGXT—nephrolithiasis	1.86e-05	0.000235	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—AQP1—nephrolithiasis	1.83e-05	0.000231	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—SPP1—nephrolithiasis	1.77e-05	0.000224	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—AQP1—nephrolithiasis	1.73e-05	0.000218	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—AQP1—nephrolithiasis	1.71e-05	0.000216	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CHRM3—nephrolithiasis	1.7e-05	0.000214	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—SPP1—nephrolithiasis	1.68e-05	0.000212	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CHRM3—nephrolithiasis	1.66e-05	0.000209	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	1.58e-05	0.0002	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APRT—nephrolithiasis	1.58e-05	0.0002	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CHRM3—nephrolithiasis	1.56e-05	0.000197	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CHRM3—nephrolithiasis	1.55e-05	0.000195	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—SPP1—nephrolithiasis	1.51e-05	0.000191	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—AQP1—nephrolithiasis	1.46e-05	0.000185	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CHRM3—nephrolithiasis	1.32e-05	0.000167	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—SPP1—nephrolithiasis	1.21e-05	0.000153	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—AQP1—nephrolithiasis	1.13e-05	0.000142	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CHRM3—nephrolithiasis	1.02e-05	0.000129	CbGpPWpGaD
